Yiwei Li

Title: Yiwei Li: Innovator in Cancer Cachexia Treatment

Introduction

Yiwei Li is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds aimed at treating cancer cachexia. His innovative work has the potential to improve the quality of life for patients suffering from this debilitating condition.

Latest Patents

Yiwei Li holds a patent for an amino dithioperacid thioester compound, along with its preparation method and applications. The structural formula of this compound is defined by specific parameters, where m ranges from 1 to 11, and X represents a nitrogen-containing aliphatic heterocyclic ring. The invention demonstrates that these compounds can alleviate muscular atrophy and lipolysis associated with cancer cachexia through both in-vivo and in-vitro experiments. Furthermore, the compounds have shown promise in mitigating weight loss and reduced food intake in animal models, making them a potential treatment option for cancer cachexia and related diseases.

Career Highlights

Throughout his career, Yiwei Li has been associated with esteemed institutions such as Fudan University and East China Normal University. His work in these academic environments has allowed him to collaborate with other researchers and contribute to advancements in medical science.

Collaborations

Some of Yiwei Li's notable coworkers include WeiLi Zhao and Xiongwen Zhang. Their collaborative efforts have furthered research in the field and enhanced the impact of their findings.

Conclusion

Yiwei Li's innovative contributions to cancer cachexia treatment highlight his role as a significant inventor in the field of medicinal chemistry. His patented compounds offer hope for improved therapeutic options for patients facing the challenges of cancer cachexia.